Skip to content

Clinical trials

Terminated Phase 4 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 4 Status: Terminated Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20111
20123

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University1
Eisai Korea Inc.1
Institute of Psychiatry, London1
Janssen-Cilag, S.A.1
Merz Pharmaceuticals GmbH1
St. Joseph's Hospital and Medical Center, Phoenix1
St. Louis University1
VA Palo Alto Health Care System1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease8
Dementia2
Cognitive Dysfunction1
Fatigue1
Lethargy1
Schizophrenia1
Sleep Initiation and Maintenance Disorders1
Sleep Wake Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.